Furthermore, the association between GFAP and COVID-19-related neurological symptoms also represents a matter of debate, which might be related to the characteristics of neurological manifestations (onset time and numbers/types of symptoms) and/or sampling time. The gene discussed is GFAP; the disease is COVID-19.